Английская Википедия:Ganitumab

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

Ganitumab is a human monoclonal antibody against type 1 insulin-like growth factor receptor (IGF1R), designed for the treatment of cancers.[1][2]

Ganitumab was developed by Amgen. A phase III clinical trial (for metastatic pancreatic cancer) was abandoned in August 2012.[3][4]

References

Шаблон:Reflist

Шаблон:Monoclonals for tumors Шаблон:Growth factor receptor modulators


Шаблон:Monoclonal-antibody-stub Шаблон:Antineoplastic-drug-stub